Discontinuation of thyroid hormone treatment among children in the United States with congenital hypothyroidism: Findings from health insurance claims data

BMC Pediatrics

Volumn 10, Issue , 2010, Pages

  Kemper, Alex R ^a   Ouyang, Lijing ^b   Grosse, Scott D ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID HORMONE; THYROTROPIN;

ARTICLE; CHILD; CONGENITAL HYPOTHYROIDISM; FEMALE; HEALTH CARE PLANNING; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; NEWBORN SCREENING; PREVALENCE; REIMBURSEMENT; RETROSPECTIVE STUDY; UNITED STATES; AGE; COMPARATIVE STUDY; DRUG UTILIZATION; FACTUAL DATABASE; INFANT; INSURANCE; NEWBORN; PRACTICE GUIDELINE; REMISSION; STATISTICS; TREATMENT WITHDRAWAL;

AGE FACTORS; CONGENITAL HYPOTHYROIDISM; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE CARRIERS; INSURANCE, HEALTH; MALE; MEDICAID; NEONATAL SCREENING; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; REMISSION, SPONTANEOUS; THYROID HORMONES; UNITED STATES; WITHHOLDING TREATMENT;

EID: 77649157891     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-10-9     Document Type: Article

References (27)

1. Bongers-Schokking JJ, de Muinck Keizer-Schrama SM. Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism. J Pediatr 2005, 147:768-774. 10.1016/j.jpeds.2005.09.031, 16356429.
2. Rovet JF. Children with congenital hypothyroidism and their siblings: do they really differ?. Pediatrics 2005, 115:e52-e57.
3. Selva KA, Harper A, Downs A, Blasco PA. eurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J Pediatr 2005, 147:N775-780.
4. Alm J, Larsson A, Zetterstrom R. Congenital hypothyroidism in Sweden: psychomotor development in patients detected by clinical signs and symptoms. Acta Paediatr 1981, 70:907-912.
5. Frost GJ, Parkin JM. A comparison between the neurological and intellectual abnormalities in children and adults with congenital hypothyroidism. Eur J Pediatr 1986, 145:480-484. 10.1007/BF02429047, 3816849.
6. Hulse JA. Outcome for congenital hypothyroidism. Arch Dis Child 1984, 59:23-29. 10.1136/adc.59.1.23, 1628400, 6198974.
7. Harris KB, Pass KA. Increase in congenital hypothyroidism in New York State and in the United States. Mol Genet Metab 2007, 91:268-177. 10.1016/j.ymgme.2007.03.012, 17512233.
8. Parks JS, Lin M, Grosse SD, Hinton CF, Drummond-Borg M, Borgfeld L, Sullivan KM. The impact of transient hypothyroidism on the increasing rate of congenital hypothyroidism in the United States. Pediatrics
9. Kurinczuk JJ, Bower C, Lewis B, Byrne G. Congenital hypothyroidism in Western Australia 1981-1998. J Paediatr Child Health 2002, 38:187-191. 10.1046/j.1440-1754.2002.00812.x, 12031004.
10. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, Sundarajan S, Varma SK. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 2006, 117:2290-2303. 10.1542/peds.2005-0582, 16740880.
11. Coakley JC, Francis I, Gold H, Mathur K, Connelly JF. Transient primary hypothyroid in the newborn: experience of the Victorian Neonatal Thyroid Screening Programme. Aust Paediatr J 1989, 25:25-30.
12. Medda E, Oliveri A, Stazi MA, Grandolfo ME, Fazzini C, Baserga M, Burroni M, Cacciari E, Calaciura F, Cassio A, Chiovato L, Costa P, Leonardi D, Martucci M, Moschini L, Pagliardini S, Parlato A, Pinchera A, Sala D, Sava L, Stoppioni V, Tancredi F, Valentini F, Vigneri R, Sorcini M. Risk factors for congenital hypothyroidism: results of a population case-control study (1997-2003). Eur J Endocrinol 2005, 153:765-773. 10.1530/eje.1.02048, 16322381.
13. Olney RS, Grosse SD, Vogt RF. Summary of workshop on prevalence of congenital hypothyroidism: current trends and future directions. Pediatrics
14. Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer 2009, 53(4):642-6. 10.1002/pbc.22069, 19492318.
15. Brosco JP, Mattingly M, Sanders LM. Impact of specific medical interventions on reducing the prevalence of mental retardation. Arch Pediatr Adolesc Med 2006, 160:302-309. 10.1001/archpedi.160.3.302, 16520451.
16. Korzeniewski SJ, Grigorescu V, Young WI. Congenital hypothyroid screening among low birth weight infants, Michigan, 2005-2007. Paper presented at: Maternal and Child Health Epidemiology Conference, 2008, Atlanta, GA
17. Jones JH, Mackenzi J, Croft GA, Beaton S, Young D, Donaldson MD. Improvement in screening performance and diagnosis of congenital hypothyroidism in Scotland 1979-2003. Arch Dis Child 2006, 91:680-685. 10.1136/adc.2005.088427, 2083034, 16595645.
18. Oakley GA, Muir T, Ray M, Girdwood RW, Kennedy R, Donaldson MD. Increased incidence of congenital malformations in children with transient thyroid-stimulating hormone elevation on neonatal screening. J Pediatr 1998, 132:726-730. 10.1016/S0022-3476(98)70369-5, 9580779.
19. Waller DK, Anderson JL, Lorey F, Cunninham GC. Risk factors for congenital hypothyroidism: an investigation of infant's birth weight, ethnicity, and gender in California, 1990-1998. Teratology 2000, 62:36-41. 10.1002/1096-9926(200007)62:1<36::AID-TERA8>3.0.CO;2-W, 10861631.
20. Deladoey J, Belanger N, Van Vliet G. Random variability in congenital hypothyroidism from thyroid dysgenesis over 16 years in Quebec. J Clin Endocrinol Metab 2007, 92:3158-3161. 10.1210/jc.2007-0527, 17504897.
21. Topaloglu AK. Athyreosis, dysgenesis, and dyshormonogenesis in congenital hypothyroidism. Pediatr Endocrinol Rev 2006, 3:498-502.
22. Sox CM, Cooper WO, Koepsell TD, DiGiuseppe DL, Christakis DA. Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA 2003, 290:1057-1061. 10.1001/jama.290.8.1057, 12941678.
23. Centers for Disease Control and Prevention (CDC) Update: newborn screening for sickle cell disease--California, Illinois, and New York, 1998. Morb Mortal Wkly Rep 2000, 49:729-731. Centers for Disease Control and Prevention (CDC).
24. Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer 2009, 53:642-646. 10.1002/pbc.22069, 19492318.
25. Yanni E, Grosse SD, Yang Q, Olney RS. Trends in pediatric sickle cell disease-related mortality in the United States, 1983-2002. J Pediatr 2009, 154:541-545. 10.1016/j.jpeds.2008.09.052, 19028391.
26. Kemper AR, Boyle CA, Aceves J, Dougherty D, Figge J, Fisch JL, Hinman AR, Greene CL, Kus CA, Miller J, Robertson D, Telfair J, Lloyd-Puryear M, van Dyck PC, Howell RR. Long-term follow-up after diagnosis resulting from newborn screening: statement of the US Secretary of Health and Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Genet Med 2008, 10:259-261. 10.1097/GIM.0b013e31816b64f9, 18414208.
27. National Coordinating Center for the Regional Genetic and Newborn Screening Collaboratives Regional Collaborative Groups. 2010, accessed January 13, 2010., National Coordinating Center for the Regional Genetic and Newborn Screening Collaboratives., http://www.nccrcg.org/AM/Template.cfm?Section=Resource_Center3